Breast Cancer

Showing NaN - NaN of 158

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer, Insomnia, Weight Gain Trial in Washington, Baltimore, Lutherville (Cognitive-Behavioral Therapy for Insomnia

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Cognitive-Behavioral Therapy for Insomnia (CBT-I)
  • Sleep Education Control (EDU)
  • Washington, District of Columbia
  • +3 more
Mar 21, 2023

Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Washington, Baltimore, Hackensack

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Washington, District of Columbia
  • +4 more
Jan 31, 2023

Breast Cancer Trial in United States (HKI-272, Surgical Resection, Capecitabine)

Active, not recruiting
  • Breast Cancer
  • San Francisco, California
  • +17 more
Jan 30, 2023

Breast Cancer Trial in United States (Positron emission tomography (PET), Trastuzumab, Pertuzumab)

Active, not recruiting
  • Breast Cancer
  • Positron emission tomography (PET)
  • +2 more
  • Birmingham, Alabama
  • +9 more
Jan 20, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Paclitaxel, Nab-paclitaxel)

Recruiting
  • Breast Cancer
  • Duarte, California
  • +260 more
Jan 19, 2023

Breast Cancer Trial in Washington, Baltimore (Outcomes4Me, Semi-structured interview)

Recruiting
  • Breast Cancer
  • Outcomes4Me
  • Semi-structured interview
  • Washington, District of Columbia
  • +1 more
Jan 13, 2023

Cancer in Patients on Dapagliflozin and Other Antidiabetic

Recruiting
  • Breast Cancer
  • Bladder Cancer
    • Wilmington, Delaware
    • +3 more
    Jan 13, 2023

    Breast Cancer, Triple Negative Breast Cancer Trial in United States (Capecitabine, Talazoparib, Atezolizumab)

    Recruiting
    • Breast Cancer
    • Triple Negative Breast Cancer
    • Washington, District of Columbia
    • +5 more
    Jan 12, 2023

    Breast Cancer Trial in Worldwide (trastuzumab, trastuzumab emtansine)

    Active, not recruiting
    • Breast Cancer
    • Anchorage, Alaska
    • +275 more
    Dec 13, 2022

    Breast Cancer Trial in Worldwide (Olaparib, Placebo)

    Active, not recruiting
    • Breast Cancer
    • Anchorage, Alabama
    • +698 more
    Nov 25, 2022

    Breast Cancer Trial in United States (Photon, Proton)

    Recruiting
    • Breast Cancer
    • Photon
    • Proton
    • Birmingham, Alabama
    • +40 more
    Nov 18, 2022

    Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

    Recruiting
    • Breast Neoplasms
    • +10 more
    • Standard Therapy
    • +32 more
    • Birmingham, Alabama
    • +35 more
    Nov 17, 2022

    Breast Cancer Trial in Worldwide (exemestane, tamoxifen, triptorelin)

    Active, not recruiting
    • Breast Cancer
    • Burbank, California
    • +227 more
    Nov 15, 2022

    TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)

    Active, not recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Breast Cancer
    • Birmingham, Alabama
    • +111 more
    Oct 25, 2022

    Breast Cancer Trial in Washington, Charlotte, Salt Lake City (Talazoparib, Avelumab)

    Active, not recruiting
    • Breast Cancer
    • Washington, District of Columbia
    • +1 more
    Oct 10, 2022

    Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

    Recruiting
    • Breast Cancer
    • +15 more
    • ATRC-101
    • +2 more
    • Phoenix, Arizona
    • +10 more
    Sep 28, 2022

    Breast Cancer Trial in United States (NeuVax vaccine, Trastuzumab, GM-CSF)

    Completed
    • Breast Cancer
    • NeuVax vaccine
    • +2 more
    • Santa Monica, California
    • +23 more
    Sep 15, 2022

    Biomarkers in Subjects With Untreated Solid Tumors

    Completed
    • Breast Cancer
    • +12 more
    • Blood Sample Collection
    • Phoenix, Arizona
    • +118 more
    Aug 31, 2022

    Malignant Tumor of Breast, Breast Cancer Trial in United States (Genomically Directed Monotherapy, Observation/Standard Therapy)

    Active, not recruiting
    • Malignant Neoplasm of Breast
    • Breast Cancer
    • Genomically Directed Monotherapy
    • Observation/Standard Therapy
    • Birmingham, Alabama
    • +28 more
    Aug 30, 2022

    Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

    Recruiting
    • Breast Cancer
    • +15 more
    • Goodyear, Arizona
    • +146 more
    Aug 24, 2022

    Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

    Recruiting
    • Mesothelioma
    • +14 more
    • Los Angeles, California
    • +13 more
    Aug 16, 2022

    Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)

    Active, not recruiting
    • Breast Cancer
    • Trastuzumab deruxtecan
    • +3 more
    • Chandler, Arizona
    • +226 more
    Aug 11, 2022

    Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)

    Active, not recruiting
    • Breast Cancer
    • Tucson, Arizona
    • +167 more
    Jul 19, 2022